Fidelity Investments’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-72
| Closed | -$547 | – | 5830 |
|
|
2024
Q2 | $547 | Buy |
+72
| New | +$547 | ﹤0.01% | 4852 |
|
|
2023
Q2 | – | Sell |
-62
| Closed | -$970 | – | 5644 |
|
|
2023
Q1 | $970 | Sell |
62
-10
| -14% | -$156 | ﹤0.01% | 4740 |
|
|
2022
Q4 | $1.43K | Sell |
72
-50
| -41% | -$995 | ﹤0.01% | 4586 |
|
|
2022
Q3 | $2K | Sell |
122
-247
| -67% | -$4.05K | ﹤0.01% | 4610 |
|
|
2022
Q2 | $8K | Buy |
369
+332
| +897% | +$7.2K | ﹤0.01% | 4196 |
|
|
2022
Q1 | $1K | Buy |
+37
| New | +$1K | ﹤0.01% | 4876 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5058 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4664 |
|
|
2018
Q3 | – | Sell |
-6,059
| Closed | -$13M | – | 3851 |
|
|
2018
Q2 | $13M | Sell |
6,059
-440
| -7% | -$943K | ﹤0.01% | 1865 |
|
|
2018
Q1 | $16.2M | Buy |
6,499
+6,143
| +1,726% | +$15.3M | ﹤0.01% | 1807 |
|
|
2017
Q4 | $634K | Buy |
+356
| New | +$634K | ﹤0.01% | 2496 |
|